TI-0032
/ Therorna
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
February 18, 2026
in vivo CAR-T: A Clinical Study of TI-0032-III Injection in Patients With Relapsed and Refractory Autoimmune Diseases
(clinicaltrials.gov)
- P1 | N=12 | Recruiting | Sponsor: Therorna
New P1 trial • Immunology • Inflammatory Arthritis • Lupus • Myositis • Scleroderma • Sjogren's Syndrome • Systemic Lupus Erythematosus • Systemic Sclerosis • Vasculitis • CD19
1 to 1
Of
1
Go to page
1